You are here
Biopharma Boot Camp Will Address Opportunities and Strategies for Life Science Companies on May 1
CLEVELAND, April 11, 2019 /PRNewswire/ -- CSSi, Ulmer & Berne LLP and BioEnterprise are hosting the Biopharma Boot Camp on May 1, 2019, from 8:00 a.m. to 11:30 a.m. at the Global Center for Health Innovation in Cleveland, Ohio.
This workshop is designed for professionals in early and later-stage life science companies who are ready to gain the foundation needed to understand the importance of a strategic roadmap and the requirements to successfully develop and commercialize a new medical technology, drug or biologic.
The list of presenters includes Peter Rome, Partner and Chair of the Business Department at Ulmer & Berne; Scott Fisher, PhD, Chief Executive Officer of CavoGene LifeSciences; Chris Trizna, President of CSSi; Russell Williams, JD, Founder and CEO of CytoSPAR; Aram Nerpouni, President and CEO of BioEnterprise; and Jim Sergi, President of CSSi LifeSciences. Speakers will discuss best practices of the industry, including:
- Corporate structuring, finance and deal term development
- Negotiating a successful technology transfer and license agreement
- The role of intellectual property in creating value
- Creating a risk-based strategic road map for medical technologies and drugs
- Requirements under FDA and the 21st Century Cures Act and a look at the latest initiatives and policies of the FDA
- Driving value through the FDA special designations
- How to design and plan a clinical study for success
Registration is required. The general admission price for this event is $25.85. To learn more about the event and to register, please visit www.cssilifesciences.com/BioPharma
About CSSi LifeSciences:
CSSi LifeSciences provides fully integrated regulatory and clinical services to support the entire product lifecycle, from discovery to commercialization, for pharmaceutical and medical device companies. With global expertise, CSSi LifeSciences has been a key partner in the development of more than 500 drugs, biologics, medical devices, and in-vitro diagnostics. The company's headquarters is located in Baltimore, MD, with additional offices in San Francisco, California and Hyderabad, India. For more information, visit: www.cssilifesciences.com.
About Ulmer & Berne:
Ulmer & Berne, established in 1908, focuses on exceeding client expectations and delivering superior, customized legal solutions for an exceptional value. From offices in Cleveland, Columbus, Cincinnati, Chicago, and Boca Raton, Ulmer's attorneys are handling cutting-edge, complex matters on a national basis across all practice areas, but retain the work ethic, rates, and user-friendly attitudes reflective of the firm's Midwest origins. Ulmer emphasizes world-class service and sophisticated industry expertise with flexible billing arrangements. For more information, visit www.ulmer.com.
BioEnterprise is a business formation, recruitment, and acceleration effort designed to grow the Northeast Ohio healthcare industry. Located in Cleveland, at the Global Center for Health Innovation and in University Circle, BioEnterprise provides management counsel and support services to health IT, medical device, and biopharmaceutical companies. In addition, BioEnterprise convenes and leads strategy for industry-building initiatives such as the Medical Capital Innovation Competition, HIT in the CLE and the Global Center for Health Innovation. BioEnterprise partners are Case Western Reserve University, Cleveland Clinic, The MetroHealth System and University Hospitals. Additional technology partners include the NASA Glenn Research Center, Cleveland State University and BioOhio. Since 2002, BioEnterprise and its partners have created, recruited and accelerated more than 350 health IT, medical device, and biopharmaceutical companies, and have helped these companies raise more than $3 billion in new funding. To learn more: www.BioEnterprise.com.
About the GCHI:
The Global Center for Health Innovation, located in Cleveland, is the platform where global healthcare leaders – industry, health systems, investors, and innovators – convene and collaborate to develop solutions to solve high-priority healthcare issues. Engaged brands include Accenture, BioEnterprise, Case Western Reserve University, Cleveland Clinic, Convelo Therapeutics, DHG Healthcare, G2G consulting, Gleeson, Global Health Metrics, HIMSS, Innovation Fund Northeast Ohio, MetroHealth System, NGP Capital, Philips Medical, Plug and Play, RiverVest Ventures, RRE Ventures, Siemens, Steris, TeamNEO, TPA Stream, University Hospitals System and multiple digital health, medical device and biotechnology startups.
PRIMARY MEDIA CONTACT:
PR & Marketing Director
SECONDARY MEDIA CONTACT:
Senior Director of Marketing & Communications
View original content to download multimedia:http://www.prnewswire.com/news-releases/biopharma-boot-camp-will-address-opportunities-and-strategies-for-life-science-companies-on-may-1-300830409.html